Drug factory · FDA FEI 3009856628

Halo Pharmaceutical Canada, Inc

17800 Lapointe, Mirabel, Canada

Canada: 1

No problems found at FDA's last inspection, Feb 17, 2023.

No Action Indicated: inspectors found no objectionable conditions.

4 drug inspections on record since 2014: 3 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
AtorvastatinMakes it Agnitio Inc., August Pharmaceutical, LLC 72134-009, 72134-010, 72134-011 +5
BetamethasoneMakes it, tests it, packages it and labels it TruPharma LLC. 52817-824
DapsoneMakes it, tests it and packages it Cosette Pharmaceuticals, Inc. 0713-0886
Dextromethorphan and PromethazineMakes it, tests it, packages it and labels it Xttrium Laboratories, Inc. 0116-4024
IndomethacinMakes it, tests it, packages it and labels it Amneal Pharmaceuticals 69238-2086
PromethazineMakes it, tests it, packages it and labels it Xttrium Laboratories, Inc. 0116-4023

FDA inspection history

EndedResultProgramProblems noted
Feb 17, 2023No problems foundDrug Quality Assurance—
Sep 15, 2017No problems foundDrug Quality Assurance—
Nov 5, 2015No problems foundDrug Quality Assurance—
Nov 14, 2014Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: analysis; label; manufacture; pack.